Home  >  Products  >  NR2C2 (nuclear receptor subfamily 2, group C, member 2) Blocking Peptide (the N terminal of protein) (100ug)
NR2C2 (nuclear receptor subfamily 2, group C, member 2) Blocking Peptide (the N terminal of protein) (100ug)

NR2C2 (nuclear receptor subfamily 2, group C, member 2) Blocking Peptide (the N terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NR2C2 antibody (Catalogue #: ARP45614_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP45614
Size: 100 ug
Weight: 67kDa
Gene: 7182
Format: Lyophilized powder
Target: Members of the nuclear hormone receptor family, such as NR2C2, act as ligand-activated transcription factors. The proteins have an N-terminal transactivation domain, a central DNA-binding domain with 2 zinc fingers, and a ligand-binding domain at the C terminus. The activated receptor/ligand complex is translocated to the nucleus where it binds to hormone response elements of target genes. Members of the nuclear hormone receptor family, such as NR2C2, act as ligand-activated transcription factors. The proteins have an N-terminal transactivation domain, a central DNA-binding domain with 2 zinc fingers, and a ligand-binding domain at the C terminus. The activated receptor/ligand complex is translocated to the nucleus where it binds to hormone response elements of target genes (Yoshikawa et al., 1996 [PubMed 8661150]).[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: TAK1; TR2R1; TR4; hTAK1